Glucagon, Lilly 1mg

Hauptinformation

  • Handelsname:
  • Glucagon, Lilly 1mg Trockensubstanz und Lösungsmittel
  • Darreichungsform:
  • Trockensubstanz und Lösungsmittel
  • Zusammensetzung:
  • Glucagonhydrochlorid (1:x) 1.05mg
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Glucagon, Lilly 1mg Trockensubstanz und Lösungsmittel
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • 46991
  • Letzte Änderung:
  • 02-12-2018

14-12-2018

Duloxetin Lilly

Rote - Liste

27-11-2018


Opinion/decision on a Paediatric investigation plan (PIP): Dasiglucagon, decision type: , therapeutic area: , PIP number: P/0220/2018

Opinion/decision on a Paediatric investigation plan (PIP): Dasiglucagon, decision type: , therapeutic area: , PIP number: P/0220/2018

Opinion/decision on a Paediatric investigation plan (PIP): Dasiglucagon, decision type: , therapeutic area: , PIP number: P/0220/2018

Europe - EMA - European Medicines Agency

21-11-2018

EU/3/18/2091 (Pharma Gateway AB)

EU/3/18/2091 (Pharma Gateway AB)

EU/3/18/2091 (Active substance: Glucagon) - Orphan designation - Commission Decision (2018)7801 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/108/18

Europe -DG Health and Food Safety

16-11-2018

Emgality (Eli Lilly Nederland B.V.)

Emgality (Eli Lilly Nederland B.V.)

Emgality (Active substance: galcanezumab) - Centralised - Authorisation - Commission Decision (2018)7672 of Fri, 16 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4648/00

Europe -DG Health and Food Safety

23-10-2018

EU/3/16/1804 (Eli Lilly Nederland B.V.)

EU/3/16/1804 (Eli Lilly Nederland B.V.)

EU/3/16/1804 (Active substance: Pegylated recombinant human interleukin-10) - Transfer of orphan designation - Commission Decision (2018)6994 of Tue, 23 Oct 2018

Europe -DG Health and Food Safety

22-10-2018

Forsteo (Eli Lilly Nederland B.V.)

Forsteo (Eli Lilly Nederland B.V.)

Forsteo (Active substance: Teriparatide) - Centralised - Yearly update - Commission Decision (2018) 6975 of Mon, 22 Oct 2018

Europe -DG Health and Food Safety

1-10-2018

Verzenios (Eli Lilly Nederland B.V.)

Verzenios (Eli Lilly Nederland B.V.)

Verzenios (Active substance: abemaciclib) - Centralised - Authorisation - Commission Decision (2018)6405 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4302

Europe -DG Health and Food Safety

24-9-2018

Cyramza (Eli Lilly Nederland B.V.)

Cyramza (Eli Lilly Nederland B.V.)

Cyramza (Active substance: ramucirumab) - Centralised - Yearly update - Commission Decision (2018)6246 of Mon, 24 Sep 2018

Europe -DG Health and Food Safety

19-9-2018

Lartruvo (Eli Lilly Nederland B.V.)

Lartruvo (Eli Lilly Nederland B.V.)

Lartruvo (Active substance: olaratumab) - Centralised - Annual renewal - Commission Decision (2018)6105 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4216/R/10

Europe -DG Health and Food Safety

23-7-2018

Optruma (Eli Lilly Nederland B.V.)

Optruma (Eli Lilly Nederland B.V.)

Optruma (Active substance: Raloxifene hydrochloride) - Centralised - Yearly update - Commission Decision (2018)4893 of Mon, 23 Jul 2018

Europe -DG Health and Food Safety

11-7-2018

Ariclaim (Eli Lilly Nederland B.V.)

Ariclaim (Eli Lilly Nederland B.V.)

Ariclaim (Active substance: duloxetine hydrochloride) - Centralised - Withdrawal - Commission Decision (2018)4515 of Wed, 11 Jul 2018

Europe -DG Health and Food Safety

3-7-2018

Olumiant (Eli Lilly Nederland B.V.)

Olumiant (Eli Lilly Nederland B.V.)

Olumiant (Active substance: baricitinib) - Centralised - Yearly update - Commission Decision (2018)4247 of Tue, 03 Jul 2018

Europe -DG Health and Food Safety

3-7-2018

Trulicity (Eli Lilly Nederland B.V.)

Trulicity (Eli Lilly Nederland B.V.)

Trulicity (Active substance: dulaglutide) - PSUSA - Modification - Commission Decision (2018)4339 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2825/PSUSA/10311/201709

Europe -DG Health and Food Safety

4-6-2018

Tadalafil Lilly (Eli Lilly Nederland B.V.)

Tadalafil Lilly (Eli Lilly Nederland B.V.)

Tadalafil Lilly (Active substance: tadalafil) - Centralised - Yearly update - Commission Decision (2018)3626 of Mon, 04 Jun 2018

Europe -DG Health and Food Safety

29-5-2018

EU/3/18/2022 (Hanmi Europe Limited)

EU/3/18/2022 (Hanmi Europe Limited)

EU/3/18/2022 (Active substance: Glucagon analogue linked to a human immunoglobulin Fc fragment) - Orphan designation - Commission Decision (2018)3389 of Tue, 29 May 2018 European Medicines Agency (EMA) procedure number: EMA/OD/257/17

Europe -DG Health and Food Safety

29-5-2018

Meloxivet (Eli Lilly and Company Limited)

Meloxivet (Eli Lilly and Company Limited)

Meloxivet (Active substance: Meloxicam) - Centralised - Withdrawal - Commission Decision (2018)3408 of Tue, 29 May 2018

Europe -DG Health and Food Safety